Cargando…

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply

Detalles Bibliográficos
Autores principales: Markusse, Iris M., Lems, Willem F., Huizinga, Tom W.J., Allaart, Cornelia F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488129/
https://www.ncbi.nlm.nih.gov/pubmed/26135890
http://dx.doi.org/10.1186/s13075-015-0681-7
_version_ 1782379102063296512
author Markusse, Iris M.
Lems, Willem F.
Huizinga, Tom W.J.
Allaart, Cornelia F.
author_facet Markusse, Iris M.
Lems, Willem F.
Huizinga, Tom W.J.
Allaart, Cornelia F.
author_sort Markusse, Iris M.
collection PubMed
description
format Online
Article
Text
id pubmed-4488129
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44881292015-07-03 Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply Markusse, Iris M. Lems, Willem F. Huizinga, Tom W.J. Allaart, Cornelia F. Arthritis Res Ther Letter BioMed Central 2015-07-02 2015 /pmc/articles/PMC4488129/ /pubmed/26135890 http://dx.doi.org/10.1186/s13075-015-0681-7 Text en © Markusse et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Letter
Markusse, Iris M.
Lems, Willem F.
Huizinga, Tom W.J.
Allaart, Cornelia F.
Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
title Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
title_full Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
title_fullStr Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
title_full_unstemmed Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
title_short Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
title_sort response to ‘feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488129/
https://www.ncbi.nlm.nih.gov/pubmed/26135890
http://dx.doi.org/10.1186/s13075-015-0681-7
work_keys_str_mv AT markusseirism responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply
AT lemswillemf responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply
AT huizingatomwj responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply
AT allaartcorneliaf responsetofeasibilityoftailoredtreatmentbasedonriskstratificationinpatientswithearlyrheumatoidarthritisauthorsreply